Literature DB >> 8968540

Increased responsiveness of human pulmonary arteries in patients with positive bronchodilator response.

E Cases1, J M Vila, P Medina, M Aldasoro, G Segarra, S Lluch.   

Abstract

1. The effects of noradrenaline, endothelin-1, acetylcholine and sodium nitroprusside were studied in isolated pulmonary arteries obtained from 14 patients undergoing lobectomy for lung carcinoma. Seven patients had shown increased response to a bronchodilator test prior to operation. In the remaining patients (control) the bronchodilator test was negative. 2. Artery rings from patients with a positive bronchodilator response showed greater contraction to noradrenaline (pD2 = 6.44 +/- 0.1; Emax = 93 +/- 9% of response to 100 mM KCl) and endothelin-1 (pD2 = 8.92 +/- 0.1; Emax = 130 +/- 16%) than the rings from control patients (pD2 = 6.04 +/- 0.08; Emax = 56 +/- 8% for noradrenaline; pD2 = 8.29 +/- 0.1; Emax = 78 +/- 10% for endothelin-1). There was no significant difference in the contractile responses to 100 mM KCl between arteries from either group of patients. 3. Arterial rings from patients with a positive bronchodilator test achieved 96 +/- 3% of maximal relaxation in response to acetylcholine, whereas rings from control patients achieved a maximal relaxation of 72 +/- 5%. Rings from both the controls and the patients with a positive bronchodilator test achieved complete relaxation in response to sodium nitroprusside but pD2 values were significantly higher in patients with a positive bronchodilator test. 4. Removal of endothelium or treatment with NG-nitro-L-arginine methyl ester of artery rings from both the control and the patients with a positive bronchodilator test reduced the relaxation to acetylcholine (P < 0.05) but did not modify relaxation to sodium nitroprusside. 5. It is concluded that responsiveness of pulmonary arterial smooth muscle to dilator and constrictor agents is increased in patients showing reversibility of airway constriction. Thus hyperresponsiveness of airway smooth muscle may be associated with a similar phenomenon in the surrounding vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968540      PMCID: PMC1915820          DOI: 10.1111/j.1476-5381.1996.tb16043.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Pulmonary endothelium-derived relaxing factor is impaired in hypoxia.

Authors:  J B Warren; N H Maltby; D MacCormack; P J Barnes
Journal:  Clin Sci (Lond)       Date:  1989-12       Impact factor: 6.124

2.  COPD: a disease of reversible air-flow obstruction.

Authors:  N J Gross
Journal:  Am Rev Respir Dis       Date:  1986-05

3.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

Authors:  L J Ignarro; H Lippton; J C Edwards; W H Baricos; A L Hyman; P J Kadowitz; C A Gruetter
Journal:  J Pharmacol Exp Ther       Date:  1981-09       Impact factor: 4.030

4.  Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations.

Authors:  R E Dales; W O Spitzer; P Tousignant; M Schechter; S Suissa
Journal:  Am Rev Respir Dis       Date:  1988-08

Review 5.  Cyclic guanosine monophosphate as a mediator of vasodilation.

Authors:  F Murad
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

Review 6.  Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents.

Authors: 
Journal:  Bull Eur Physiopathol Respir       Date:  1983 Sep-Oct

Review 7.  Bronchial hyperreactivity.

Authors:  H A Boushey; M J Holtzman; J R Sheller; J A Nadel
Journal:  Am Rev Respir Dis       Date:  1980-02

8.  Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia.

Authors:  S Adnot; B Raffestin; S Eddahibi; P Braquet; P E Chabrier
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach.

Authors:  N Meslier; J L Racineux; P Six; A Lockhart
Journal:  Eur Respir J       Date:  1989-06       Impact factor: 16.671

10.  Influence of endothelial nitric oxide on neurogenic contraction of human pulmonary arteries.

Authors:  C Martínez; E Cases; J M Vila; M Aldasoro; P Medina; V Marco; S Lluch
Journal:  Eur Respir J       Date:  1995-08       Impact factor: 16.671

View more
  3 in total

Review 1.  Hypoxic pulmonary vasoconstriction in humans.

Authors:  Priyadharshanan Ariyaratnam; Mahmoud Loubani; Alyn H Morice
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

Review 2.  Role of endothelin-1 in lung disease.

Authors:  K A Fagan; I F McMurtry; D M Rodman
Journal:  Respir Res       Date:  2001-02-22

Review 3.  Hypoxic Pulmonary Vasoconstriction in Humans: Tale or Myth.

Authors:  A Hussain; M S Suleiman; S J George; M Loubani; A Morice
Journal:  Open Cardiovasc Med J       Date:  2017-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.